The other side of the coin:

Safety issues regarding mesenchymal stem cells-based therapy

Despite these promising results, safety issues regarding mesenchymal stem cells-based therapy are still a matter of debate, especially in the long-term follow up. The primary concern is unwanted differentiation of the transplanted mesenchymal stem cells and their potential to suppress anti-tumor immune response and generate new blood vessels that may promote tumor growth and metastasis.